Gender, autoantibodies, and obesity in newly diagnosed diabetic patients aged 40-75 years

Diabetes Care
M WroblewskiG Sundkvist

Abstract

To evaluate the frequency of autoimmune markers (islet cell antibodies (ICA] and glutamic acid decarboxylase antibodies [GADA]) and clinical features in newly diagnosed people with diabetes aged 40-75 years. Two hundred fifty-nine consecutive patients (aged 40-75 years) with newly suspected diabetes diagnosed during a 2-year period were studied. The diagnosis of newly discovered diabetes was confirmed in 203 patients. Gender, BMI, HbA1c, fasting C-peptide, ICA, and GADA were evaluated. The frequency of obesity was estimated using two different sets of criteria: 1) National Diabetes Data Group (NDDG) criteria, and 2) criteria based on a Swedish reference population. The annual incidence of diabetes was 106 per 100,000 people. The incidence of diabetes in those patients who were 40-54 years old was significantly higher in men than in women (odds ratio: 2.16; P = 0.001). ICA were detected in 16 of 203 patients (8%), whereas 17 of 203 patients (8%) were GADA+; 10 of 203 (5%) patients were positive for both ICA and GADA. Among the 203 diabetic patients, 19 (9.4%) were classified as having IDDM, giving an IDDM incidence of 10 per 100,000 people aged 40-75 years. The frequency of obesity in NIDDM was high but varied with its definitio...Continue Reading

Citations

Jun 10, 2006·Clinical Autonomic Research : Official Journal of the Clinical Autonomic Research Society·Anders GottsäterGöran Sundkvist
Oct 30, 1999·Clinical and Experimental Immunology·P GargiuloJ A McIntyre
Oct 29, 2000·Diabetic Medicine : a Journal of the British Diabetic Association·T M DavisI R Mackay
Oct 29, 2000·Diabetic Medicine : a Journal of the British Diabetic Association·I Bourdel-MarchassonJ F Dartigues
May 6, 1999·The New England Journal of Medicine·O Pinhas-Hamiel, P Zeitler
Feb 25, 2006·European Journal of Endocrinology·S GenoveseP Pozzilli
Feb 20, 2014·Acta Diabetologica·Michael Lynge PedersenMarit Eika Jørgensen
Mar 5, 2013·Gaceta sanitaria·Luis ForgaUNKNOWN En Representación del Grupo de Estudio de Diabetes tipo 1 de Navarra
Sep 23, 2008·Diabetes Research and Clinical Practice·M ThunanderM Landin-Olsson
May 15, 2007·Diabetes & Metabolism·B EliassonUNKNOWN Steering Committee of the Swedish National Diabetes Register (NDR)
Jan 17, 2007·Metabolism: Clinical and Experimental·Ebenezer NyenweChukwuma Ogugua
Sep 24, 2005·Diabetic Medicine : a Journal of the British Diabetic Association·B EliassonUNKNOWN Steering Committee of the Swedish National Diabetes Register
Mar 13, 2003·Diabetes, Obesity & Metabolism·Sanjay RatnakantSolomon S Solomon
Jun 6, 2003·Diabetic Medicine : a Journal of the British Diabetic Association·A GottsäterG Sundkvist
Feb 16, 2006·Journal of Internal Medicine·M RidderstråleUNKNOWN Steering Committee of the Swedish National Diabetes Register (NDR)
Nov 22, 2007·Diabetic Medicine : a Journal of the British Diabetic Association·A W van DeutekomS Simsek
Jul 1, 2009·Saudi Journal of Ophthalmology : Official Journal of the Saudi Ophthalmological Society·Maha ShahinMohamed Mabed
Oct 27, 2005·Diabetes Care·Graziella BrunoUNKNOWN Piedmont Study Group for Diabetes Epidemiology
Jan 3, 2001·The Journal of Clinical Endocrinology and Metabolism·C TörnJ Ostman
Aug 14, 2020·BMJ : British Medical Journal·Alexandra E Butler, David Misselbrook
Apr 29, 2008·Arquivos brasileiros de endocrinologia e metabologia·Maria Regina CalsolariSaulo Purisch
Feb 20, 2021·Curēus·Yetunde B OmotoshoArvin Junn P Mallari

❮ Previous
Next ❯

Related Concepts

Related Feeds

American Diabetes Association Journals

Discover the latest diabetes research published by the journals from the American Diabetes Association.

Autoimmune Diabetes & Tolerance

Patients with type I diabetes lack insulin-producing beta cells due to the loss of immunological tolerance and autoimmune disease. Discover the latest research on targeting tolerance to prevent diabetes.

Biomarkers for Type 2 Diabetes

Biomarkers can help understand chronic diseases and assist in risk prediction for prevention and early detection of diseases. Here is the latest research on biomarkers in type 2 diabetes, a disease in which the body is unable to produce or properly use insulin.